CLOSE X

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE2298.60113.45 (+5.19 %)
PREV CLOSE ( ) 2185.15
OPEN PRICE ( ) 2203.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 60814
TODAY'S LOW / HIGH ( )2185.40 2307.05
52 WK LOW / HIGH ( )1575 2395
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 20-03 1978
Management Info
Srinivas Sadu - Chairman - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com / investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
02Jun Gland Pharma informs about allotment
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
18May Gland Pharma’s consolidated net profit
Gland Pharma has reported results for the fourth quarter (Q4FY26) and ye..
18May Gland Pharma shines on reporting jumps
Gland Pharma is currently trading at Rs. 2138.55, up by 271.45 points or..
16May Gland Pharma informs about newspaper a
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
15May Grant Of Stock Options Under Gland Ph
Grant of Stock Options under Gland Pharma Employee Stock Option Scheme 2025
Financials
Rs. in Millions
QTR Mar 26 ANNUAL 26
Net Profit4204.5112995.51
Gross Profit 5647.99 17483.11
Operating Profit 6140.7419669.73
Net Sales 12615.9245520.92
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 18082.15 (5.12%)
M.Cap ( in Cr)23199.20
Venus Remedies (BSE)
 1765.55 (4.10%)
M.Cap ( in Cr)2360.01
CORONA Remedies (BSE)
 1914.05 (3.59%)
M.Cap ( in Cr)11706.35
Sanofi India (BSE)
 3411.05 (1.85%)
M.Cap ( in Cr)7855.86
Torrent Pharma (BSE)
 4514.15 (1.27%)
M.Cap ( in Cr)152779.35
Shareholding Pattern
PROMOTERS 51.83%
MUTUAL FUNDS/UTI 31.78%
NON-INSTITUTION 7.52%
FI/BANKS/INSURANCE 1.35%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data May 2026 Broking Complaints Data May 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.